Cardiac damage induced by renal ischemia/reperfusion injury in hyperlipidemic rats: Role of PPAR-α agonist

Hong Kong Journal of Nephrology

Volumn 11, Issue 2, 2009, Pages 59-65

  Bhalodia, Yagnik ^a   Sheth, Navin ^b   Vaghasiya, Jitendra ^a   Jivani, Nurudin ^a  

^a SNDT WOMEN S UNIVERSITY   (India)

^b SAURASHTRA UNIVERSITY   (India)

Author keywords

Cardiac damage; Fenofibrate; Ischemia reperfusion; Kidney; Oxidative stress

Indexed keywords

ARACHIS OIL; CATALASE; CHOLESTEROL; FENOFIBRATE; GLUTATHIONE; METHYLCELLULOSE; MYELOPEROXIDASE; NITRIC OXIDE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFICACY; HEART INJURY; HYPERLIPIDEMIA; ISOLATED HEART; KIDNEY ISCHEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 70350736059     PISSN: 15615413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1561-5413(09)60244-1     Document Type: Article

References (33)

1. Campbell JD. Lifestyle, minerals and health. Med Hypotheses 2001;57:521-531
2. Snively CS, Gutierrez C. Chronic kidney disease: prevention and treatment of common complications. Am Fam Physician 2004;70:1921-1928 (Pubitemid 39532193)
3. Kumai T, Oonuma S, Kitaoka Y, Tadokoro M, Kobayashi S. Biochemical and morphological characterization of spontaneously hypertensive hyperlipidaemic rats. Clin Exp Pharmacol Physiol 2003;30:537-544 (Pubitemid 37011591)
4. Madore F. Vascular risk factors and renal failure. Med Sci 2004;20:1100-1103 (Pubitemid 40012801)
5. Campos SB, Ori M, Dórea EL, Seguro AC. Protective effect of L-arginine on hypercholesterolemia-enhanced renal ischemic injury. Atherosclerosis 1999;143:327-334 (Pubitemid 29166913)
6. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003;14:1549-1558 (Pubitemid 36687056)
7. Erdogan H, Fadillioglu E, Yagmurca M, Ucar M, Irmak MK. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 2006;34:41-46 (Pubitemid 43234713)
8. Serteser M, Koken T, Kahraman A, Yilmaz K, Akbulut G, Dilek ON. Changes in hepatic TNF-α levels, antioxidant status, and oxidation product after renal ischemia/reperfusion injury in mice. J Sur Res 2002;107:234-240 (Pubitemid 35385629)
9. Finck BN, Kelly DP. Peroxisome proliferator-activated receptor-α (PPAR-α) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J Mol Cell Cardiol 2002;34:1249-1257
10. Patel NS, di Paola R, Mazzon E, Britti D, Thiemermann C, Cuzzocrea S. Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury. J Pharmacol Exp Ther 2009;328:635-643
11. Ahila S, Chatterjee P, Hattori Y, Brown P, Stewart K, Todorovic Z, et al. Agonists of peroxisome-proliferator activated receptor-alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat. Med Sci Monit 2002;8:532-539 (Pubitemid 36119176)
12. Kumari CS, Govindasamy S, Sukumar E. Lipid lowering activity of Eclipta prostrate in experimental hyperlipidemia. J Ethnopharmacol 2006;105:332-335
13. Kontogiannis J, Burns KD. Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 1998;274(1 Pt 2):F79-90. (Pubitemid 28133976)
14. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in liver fractions in vitro. Biochem J 1971;123:805-814
15. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. In: Packer L, Glazer AN, eds. Methods in Enzymology, Oxygen Radicals in Biological Systems. California: Academic Press, 1990;186:464-478
16. Moran MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67. (Pubitemid 9065588)
17. Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay of SOD. J Biol Chem 1972;247:3170.
18. Aebi H. Oxidoreductases acting on groups other than CHOH: catalase. In: Colowick SP, Kaplan NO, Packer L, eds. Methods in Enzymology. London: Academic Press, 1984;105:121-125
19. Varley H. Practical Clinical Biochemistry. New Delhi: CBS Publishers, 1988.
20. Prajda N, Weber G. Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett 1975;59:245-249
21. Guevara I, Iwanejko J, Dembinska-Kiec A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction, Clin Chim Acta 1998;274:177-188 (Pubitemid 28269300)
22. Wei H, Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 1993;14:1195-201. (Pubitemid 23193551)
23. Huang E, Kuo W, Chen Y, Chen T, Chang M, Lu M, et al. Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta 2006;366:293-298 (Pubitemid 43330998)
24. Hagar HH. Folic acid and vitamin B12 supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats. Pharmacol Res 2002;46:213-219
25. Matsuyama M, Yoshimura R, Hase T, Kawahito Y, Sano H, Nakatani T. Study of cyclooxygenase-2 in renal ischemia-reperfusion injury. Transplant Proc 2005;37:370-372 (Pubitemid 40459789)
26. Arnhold J, Osipov AN, Spalteholz H, Panasenko OM, Schiller J. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic Biol Med 2001;31:1111-1119 (Pubitemid 33000133)
27. Yagmurca M, Erdogan H, Iraz M, Songur A, Ucar M, Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 2004;348:27-34.
28. Ma XL, Lopez BL, Liu GL, Christopher TA, Gao F, Guo Y, et al. Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury. Circ Res 1997;80:894-901. (Pubitemid 27230065)
29. Onody A, Csonka C, Giricz Z, Ferdinandy P. Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 2003;58:663-670 (Pubitemid 36694452)
30. Dominique D, Gele P, Petrault O, Six I, Furman C, Bouly M, et al. Peroxisome proliferator activated receptor-α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 2003;23:6264-6271 (Pubitemid 36875628)
31. Chen XR, Besson VC, Palmier B, Garcia Y, Plotkine M, Leroux CM. Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. J Neurotrauma 2007;24:1119-1131
32. Kładna A, Aboul-Enein HY, Kruk I, Lichszteld K, Michalska T. Scavenging of reactive oxygen species by some nonsteroidal anti-inflammatory drugs and fenofibrate. Biopolymers 2006;82:99-105. (Pubitemid 43798158)
33. Wu J, Lin J, He Z, Ou B, Guo H. Effect of hyperlipidemia on endothelial VCAM-1 expression and the protective role of fenofibrate. Front Med China 2007;1:356-358